Abstract:Background: Previous study reveals that, exogenous bone marrow mesenchymal stem cells (MSCs) may settle down in kidney and differentiate into renal cells, as well as participate in the repair of injured renal tissues. However, the repairing pathway is unclear. Objective: To investigate the potential effect of exogenous MSCs transplantation on renal injury. Design, time and setting: An in vivo trial of cytology was performed in the Urinary Surgery Institute of Nanchang University (Nanchang, Jiangxi, China) from March to September in 2007. Materials: Fifty-six SD rats of clean grade were recruited. Eight male rats of them were used to prepare MSCs, while other 48 female rats were divided into three groups at random, namely cell transplantation group, model control group and sham group. Each group contained 16 rats. Fluorochrome DAPI was a product of Biotium Inc. Ricinus communis agglutinin was produced by Vector Laboratories. BrdU was offered by Sigma. Methods: Bone marrow-derived MSCs were collected from male SD rats, then isolated by Percoll density gradient centrifugation and labeled with DAPI at a density of 1.5 × 1010/L. Renal injury models induced by ischemia and reperfusion were created in cell transplantation group and model control, while renal vessels were not ligated in the sham group. SD rats were subjected to clamping renal pedicles for 45 minutes. DAPI-labeled MSCs or 1 mL saline were transplanted into the rats by inferior vena cava in cell transplantation group or model control group and sham group. All animals received daily injection of BrdU, then blood and renal tissues were sampled. Main outcome measures: Immunohistochemical methods and fluorescence microscope were performed to identify transplanted MSCs and BrdU in renal tissues. To confirm if the MSCs may differentiate into renal tubular cells, ricinus communis agglutinin that binds specifically to the luminal surface of tubules was used. Biochemistry methods were used to detect the levels of creatinine and blood urea nitrogen in serum. Results: At day 3 after transplantation, the DAPI-positive cells were few, but obviously increased at day 4 (P < 0.05). Most of DAPI-labeled cells could express ricinus communis agglutinin-positive cells simultaneously and were mainly distributed in the renal tubule. There were few positive cells in renal cortex and kidney inner medullary, even absent in renal glomerulus. In sham group, the renal tissue cells proliferated slowly, and BrdU-positive cells were remarkably lower than that in model control group at day 4 (P < 0.05); BrdU-positive cells were distributed identically with DAPI-positive cells in the cell transplantation and model control groups at days 2, 3 and 4, but the BrdU-positive cells in transplantation group were much more than that of the control group (P < 0.05) Compared with the model control group, the serum level of blood urea nitrogen in cell transplantation group was significantly decreased at days 1 and 2 (P < 0.05), and the serum levels of creatinine were significantly lower at days 1, 2 and 3 (P < 0.05). Conclusion: Exogenous MSCs can migrate and repopulate in the ischemically injured kidney, differentiate into renal tubular cells and promote cells proliferation to repair renal injury. MSCs have depressant effect on increasing degrees of blood urea nitrogen and creatinine at early stage, this protective effect has no association with location and differentiation of MSCs.

Micro‐vesicles Derived from Bone Marrow Stem Cells Protect the Kidney Both in Vivo and in Vitro by Microrna‐dependent Repairing

Micro-vesicles derived from bone marrow stem cells protect the kidney both in vivo and in vitro by microRNA-dependent repairing (vol 20, pg 591, 2015)

Targeted Delivery of Bone Mesenchymal Stem Cells by Ultrasound Destruction of Microbubbles Promotes Kidney Recovery in Acute Kidney Injury

Bone Marrow Stem Cells-Derived Microvesicles Protect Against Renal Injury in the Mouse Remnant Kidney Model

Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo

Mesenchymal Stem Cells–microvesicle-Mir-451a Ameliorate Early Diabetic Kidney Injury by Negative Regulation of P15 and P19

Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro

Regenerative Abilities of Mesenchymal Stem Cells Via Acting As an Ideal Vehicle for Subcellular Component Delivery in Acute Kidney Injury

Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Tubular Epithelial Cell Dedifferentiation and Growth Via Hepatocyte Growth Factor Induction

Bone marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model.

Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury

Microvesicles Derived from Human Wharton’s Jelly Mesenchymal Stromal Cells Ameliorate Renal Ischemia-Reperfusion Injury in Rats by Suppressing CX3CL1

A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles

Arterially Transplanted Mesenchymal Stem Cells in a Mouse Reversible Unilateral Ureteral Obstruction Model: in Vivo Bioluminescence Imaging and Effects on Renal Fibrosis

Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning

Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles as Natural Nanocarriers in the Treatment of Nephrotoxic Injury In Vitro

Exosomes derived from mesenchymal stem cells ameliorate renal fibrosis via delivery of miR-186-5p

Bone marrow mesenchymal stem cells reduce ureteral stricture formation in a rat model via the paracrine effect of extracellular vesicles

Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Alleviate Renal Ischemic Reperfusion Injury and Enhance Angiogenesis in Rats.

Bone marrow mesenchymal stem cells transplantation for the repair of renal injury

Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA/ROCK pathway, in a UUO rat model